Mayo Clinic's approach

A team of doctors and staff in a group in a discussion. Mayo Clinic VAD team

A healthcare team discusses left ventricular assist device (LVAD) care.

At Mayo Clinic, doctors trained in heart disease (cardiologists), doctors trained in heart surgery (cardiovascular surgeons) and other health care providers work together to deliver coordinated, comprehensive care.

  • Individualized approach. Healthcare professionals at Mayo Clinic care for you as a whole person. They take the time to get to know you and work with you to provide exactly the care you need.
  • Pediatric expertise. Sometimes a child may need a ventricular assist device. Doctors trained in pediatric cardiology and cardiovascular surgery care for children who have heart disease at Mayo Clinic's campus in Minnesota.
  • Advanced treatment. Mayo Clinic provides many innovative treatments for people with advanced heart failure. Ventricular assist devices may be a treatment option for complex heart conditions such as restrictive cardiomyopathy, amyloidosis and other high-risk conditions.
  • Accessible locations. Mayo Clinic's campuses in Arizona, Florida and Minnesota each offer a Heart Failure Clinic with a team of cardiologists and other healthcare professionals trained in evaluating and treating heart failure. Each of these three sites are served by international airports.
  • Innovative research. Mayo surgeons use their expertise to develop new designs of ventricular assist devices to use in specific cases.

The Mayo Clinic experience and patient stories

Our patients tell us that the quality of their interactions, our attention to detail and the efficiency of their visits mean health care like they've never experienced. See the stories of satisfied Mayo Clinic patients.

  1. Alan-and-Vida-Lewis-16x9--1024x576.jpg

    Bariatric surgery paves way for heart transplant after end-stage heart failure 

    With a failing heart and little hope of healing, Alan Lewis sunk into depression, gaining 330 pounds. After he came to Mayo, bariatric surgery enabled the transplant he'd sought for so many years.    Alan Lewis was lying on the floor — the only position that eased his discomfort — watching a football game. When a Mayo Clinic commercial came on, the tagline seemed to leap off the screen. "You know where to go." With…

  2. Loren-Vinal_Patient_AJ-Rodgers_Nurse-16x9-1-1024x576.jpg

    New heart helps Loren Vinal return to music, life he loves

    Loren Vinal plays the guitar with AJ Rodgers, a heart transplant nurse practitioner at Mayo Clinic in Florida. For Loren Vinal, the holidays have always carried a gentle kind of magic. Loren's hometown of Corning, New York, and his winters on Jekyll Island, Georgia, offered two peaceful places where music and community shaped his daily life. In late 2017, everything changed. After months of worsening shortness of breath and repeated misdiagnoses, Loren — a guitarist with 40 years…

  3. Sue-Baker-1024x576.jpg

    A Mayo first: Innovative transplant procedure saves patient's life after heart failure

    Sue Baker Sue Baker started having issues with her heart in 2015. By 2019, she began experiencing heart failure. Living in Southeast Georgia, her condition landed her in the hospital seven times before the last visit led to her being transferred to Mayo Clinic in Florida, nearly 90 minutes away, critically ill. "She was really sick — in cardiogenic shock, intubated, connected to a breathing machine — she was not going to make it," says…

Expertise and rankings

Mayo Clinic cardiologists and cardiovascular surgeons have expertise in treating people who may need ventricular assist devices (VADs). Each year, about 150 people have ventricular assist devices implanted at Mayo Clinic.

A team of Mayo health care providers discusses ventricular assist device care. Mayo Clinic VAD care team

A team of Mayo healthcare professionals talk about ventricular assist device care.

Nationally recognized expertise

Mayo Clinic campuses are nationally recognized for expertise in cardiology and cardiovascular surgery:

  • Mayo Clinic in Rochester, Minnesota, Mayo Clinic in Phoenix/Scottsdale, Arizona, and Mayo Clinic in Jacksonville, Florida, are ranked among the Best Hospitals for heart and heart surgery by U.S. News & World Report.
  • Mayo Clinic Children's in Rochester is ranked the No. 1 hospital in Minnesota and the five-state region of Iowa, Minnesota, North Dakota, South Dakota and Wisconsin, according to U.S. News & World Report's 2025–2026 "Best Children's Hospitals" rankings.
A group of doctors and staff having a discussion. Mayo Clinic care team

Mayo Clinic healthcare professionals work as a team to care for people who may need ventricular assist devices.

With Mayo Clinic's emphasis on collaborative care, specialists at each of the campuses — Arizona, Minnesota and Florida — interact closely with colleagues at the other campuses and Mayo Clinic Health System.

Learn more about Mayo Clinic's cardiovascular surgery and cardiovascular medicine departments' expertise and rankings.

Locations, travel and lodging

Mayo Clinic has major campuses in Phoenix and Scottsdale, Arizona; Jacksonville, Florida; and Rochester, Minnesota. The Mayo Clinic Health System has dozens of locations in several states.

For more information on visiting Mayo Clinic, choose your location below:

Costs and insurance

Mayo Clinic works with hundreds of insurance companies and is an in-network provider for millions of people.

In most cases, Mayo Clinic doesn't require a physician referral. Some insurers require referrals or may have additional requirements for certain medical care. All appointments are prioritized on the basis of medical need.

Learn more about appointments at Mayo Clinic.

Please contact your insurance company to verify medical coverage and to obtain any needed authorization prior to your visit. Often, your insurer's customer service number is printed on the back of your insurance card.

More information about billing and insurance:

Mayo Clinic in Arizona, Florida and Minnesota

Mayo Clinic Health System

Sept. 03, 2026
  1. Adamopoulos S, et al. Right heart failure with left ventricular assist devices: Preoperative, perioperative and postoperative management strategies. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC. European Journal of Heart Failure. 2024; doi:10.1002/ejhf.3323.
  2. Ahmed MM, et al. Timing and outcomes of concurrent and sequential biventricular assist device implantation: A Society of Thoracic Surgeons Intermacs analysis. The Annals of Thoracic Surgery. 2023; doi:10.1016/j.athoracsur.2023.02.058.
  3. Albulushi A, et al. Effectiveness of mechanical circulatory support devices in reversing pulmonary hypertension among heart transplant candidates: A systematic review. Current Problems in Cardiology. 2024; doi:10.1016/j.cpcardiol.2024.102579.
  4. Amir O, et al. Cardiac implantable electronic and other monitoring devices in continuous-flow left ventricular assist device patients. A clinical consensus statement of the Heart Failure Association and the European Heart Rhythm Association of the ESC. European Journal of Heart Failure. 2025; doi:10.1002/ejhf.3635.
  5. Aslam S, et al. The International Society for Heart and Lung Transplantation (ISHLT): 2024 infection definitions for durable and acute mechanical circulatory support devices. Journal of Heart and Lung Transplantation. 2024; doi:10.1016/j.healun.2024.03.004.
  6. Birati EY, et al. Outcomes following isolated right ventricular assist device as durable support for primary right heart failure: An INTERMACS analysis. JHLT Open. 2025; doi:10.1016/j.jhlto.2025.100258.
  7. Chamogeorgakis T, et al. Treatment strategies and outcomes of right ventricular failure post left ventricular assist device implantation: An INTERMACS analysis. ASAIO Journal. 2024; doi:10.1097/MAT.0000000000002105.
  8. Crespo-Diaz R. Permanent left ventricular assist devices: Long-term management and outcomes. Clinics in Chest Medicine. 2026; doi:10.1016/j.ccm.2026.04.014.
  9. Estep JD, et al. Recommendations for multimodality imaging of patients with left ventricular assist devices and temporary mechanical support: Updated recommendations from the American Society of Echocardiography. Journal of the American Society of Echocardiography. 2024; doi:10.1016/j.echo.2024.06.005.
  10. Heidenreich PA, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; doi:10.1161/CIR.0000000000001063.
  11. Hollis IB, et al. An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device. Journal of Heart and Lung Transplantation. 2024; doi:10.1016/j.healun.2024.04.065.
  12. Implantable medical devices. American Heart Association. https://www.heart.org/en/health-topics/heart-attack/treatment-of-a-heart-attack/implantable-medical-devices. Accessed Aug. 17, 2026.
  13. Kambič T, et al. Effects of exercise training in left ventricular assist device patients: A systematic review with an individual participant data meta-analysis. Heart. 2026; doi:10.1136/heartjnl-2025-326962.
  14. Mehaffey JH, et al. Survival after left ventricular assist device: A Society of Thoracic Surgeons National Intermacs Database risk model assessment. The Annals of Thoracic Surgery. 2026; doi:10.1016/j.athoracsur.2026.01.040.
  15. Mehra MR, et al. Aspirin and hemocompatibility events with a left ventricular assist device in advanced heart failure: The ARIES-HM3 randomized clinical trial. JAMA. 2023; doi:10.1001/jama.2023.23204.
  16. Mehra MR, et al. Five-year outcomes in patients with fully magnetically levitated vs axial-flow left ventricular assist devices in the MOMENTUM 3 randomized trial. JAMA. 2022; doi:10.1001/jama.2022.16197.
  17. Meyer AL, et al. Hybrid durable biventricular assist device implantation with Berlin Heart EXCOR pulsatile RVAD and a continuous flow LVAD. Journal of Heart and Lung Transplantation. 2026; doi:10.1016/j.healun.2026.02.1674.
  18. Meyer DM, et al. The Society of Thoracic Surgeons Intermacs 2024 annual report: Focus on outcomes in younger patients. The Annals of Thoracic Surgery. 2025; doi:10.1016/j.athoracsur.2024.10.003.
  19. Nayak A, et al. The Society of Thoracic Surgeons Intermacs 2025 annual report: Focus on outcomes in older adults. The Annals of Thoracic Surgery. 2026; doi:10.1016/j.athoracsur.2025.10.005.
  20. Nayak A, et al. Predictors of 5-year mortality in patients managed with a magnetically levitated left ventricular assist device. Journal of the American College of Cardiology. 2023; doi:10.1016/j.jacc.2023.05.066.
  21. Pagani FD, et al. The Society of Thoracic Surgeons National Intermacs Database risk model for durable left ventricular assist device implantation. The Annals of Thoracic Surgery. 2025; doi:10.1016/j.athoracsur.2024.11.039.
  22. Peichl P, et al. Drug therapy and catheter ablation for management of arrhythmias in continuous flow left ventricular assist device’s patients: A clinical consensus statement of the European Heart Rhythm Association and the Heart Failure Association of the ESC. Europace. 2024; doi:10.1093/europace/euae272.
  23. Peled Y, et al. International Society for Heart and Lung Transplantation guidelines for the evaluation and care of cardiac transplant candidates — 2024. Journal of Heart and Lung Transplantation. 2024; doi:10.1016/j.healun.2024.05.010.
  24. Rali AS, et al. A critical care cardiology perspective on managing acute emergencies in patients with durable ventricular assist devices. Journal of the American College of Cardiology. 2026; doi:10.1016/j.jacc.2025.11.054.
  25. Rosano GMC, et al. The use of left ventricular ejection fraction in the diagnosis and management of heart failure. A clinical consensus statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS). European Journal of Heart Failure. 2025; doi:10.1002/ejhf.3646.
  26. Saeed D, et al. The 2023 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: A 10-year update. Journal of Heart and Lung Transplantation. 2023; doi:10.1016/j.healun.2022.12.004.
  27. Sener YZ, et al. Left ventricular recovery and outcomes in patients with a durable left ventricular assist device: The EUROMACS registry. European Heart Journal. 2026; doi:10.1093/eurheartj/ehag477.
  28. Tedford RJ, et al. Durable mechanical circulatory support: JACC scientific statement. Journal of the American College of Cardiology. 2023; doi:10.1016/j.jacc.2023.07.019.
  29. Trachtenberg B, et al. HFSA expert consensus statement on the medical management of patients on durable mechanical circulatory support. Journal of Cardiac Failure. 2023; doi:10.1016/j.cardfail.2023.01.009.
  30. Usman AA, et al. Outcomes of temporary right ventricular assist device at the time of durable left ventricular assist device implantation. ASAIO Journal. 2026; doi:10.1097/MAT.0000000000002795.

Ventricular assist device (VAD)